Literature DB >> 17966004

Outcome of undisplaced and moderately displaced femoral neck fractures.

Kristian Bjørgul1, Olav Reikerås.   

Abstract

BACKGROUND: The optimal treatment for femoral neck fracture is a matter of controversy. We compared the outcome of displaced fractures with good healing potential (moderately displaced fractures) to the outcome of undisplaced fractures treated by internal fixation with 2 parallel screws.
METHODS: In a consecutive series of hip fracture patients, the rates of reoperation and mortality for 225 undisplaced fractures were compared to those for 241 moderately displaced fractures. The patients were followed for 1-6 years.
RESULTS: The total rate of reoperation was 19% (9% because of healing complications) for the undisplaced fractures and 33% (20% because of healing complications) for the moderately displaced fractures. Fracture displacement was the main predictor of reoperation. There was no difference in mortality between the groups, and patient-related background parameters (rather than fracture displacement) were the main predictors of mortality.
INTERPRETATION: Undisplaced fractures should be treated by internal fixation. The best treatment for moderately displaced fractures remains to be determined.

Entities:  

Mesh:

Year:  2007        PMID: 17966004     DOI: 10.1080/17453670710014149

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  22 in total

1.  Contemporary management of femoral neck fractures: the young and the old.

Authors:  David A Forsh; Tania A Ferguson
Journal:  Curr Rev Musculoskelet Med       Date:  2012-09

2.  Is percutaneous screw fixation really superior to non-operative management after valgus-impacted femoral neck fracture: a retrospective cohort study.

Authors:  L Henry Goodnough; Harsh Wadhwa; Andrew T Fithian; Malcolm R DeBaun; Sean T Campbell; Michael J Gardner; Julius A Bishop
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-07-24

3.  Serum albumin and fixation failure with cannulated hip screws in undisplaced intracapsular femoral neck fracture.

Authors:  O Riaz; R Arshad; S Nisar; R Vanker
Journal:  Ann R Coll Surg Engl       Date:  2016-04-08       Impact factor: 1.891

4.  Clinical results of treatment of garden type 1 and 2 femoral neck fractures in patients over 70-year old.

Authors:  S K Han; H S Song; R Kim; S H Kang
Journal:  Eur J Trauma Emerg Surg       Date:  2015-04-18       Impact factor: 3.693

5.  Revision surgery occurs frequently after percutaneous fixation of stable femoral neck fractures in elderly patients.

Authors:  Michael S Kain; Andrew J Marcantonio; Richard Iorio
Journal:  Clin Orthop Relat Res       Date:  2014-09-26       Impact factor: 4.176

6.  The Result of In Situ Pinning for Valgus Impacted Femoral Neck Fractures of Patients over 70 Years Old.

Authors:  Yoon-Chung Kim; Joo-Yup Lee; Joo-Hyoun Song; Seungbae Oh
Journal:  Hip Pelvis       Date:  2014-12-31

Review 7.  Excess mortality following hip fracture: a systematic epidemiological review.

Authors:  B Abrahamsen; T van Staa; R Ariely; M Olson; C Cooper
Journal:  Osteoporos Int       Date:  2009-05-07       Impact factor: 4.507

8.  Treatment and displacement affect the reoperation rate for femoral neck fracture.

Authors:  Donavan K Murphy; Timmothy Randell; Kindyle L Brennan; Robert A Probe; Michael L Brennan
Journal:  Clin Orthop Relat Res       Date:  2013-05-03       Impact factor: 4.176

9.  Progression of a fracture site impaction as a prognostic indicator of impacted femoral neck fracture treated with multiple pinning.

Authors:  Pil Whan Yoon; Young Ho Shin; Jeong Joon Yoo; Kang Sup Yoon; Hee Joong Kim
Journal:  Clin Orthop Surg       Date:  2012-02-20

10.  A new measurement for posterior tilt predicts reoperation in undisplaced femoral neck fractures: 113 consecutive patients treated by internal fixation and followed for 1 year.

Authors:  Henrik Palm; Kasper Gosvig; Michael Krasheninnikoff; Steffen Jacobsen; Peter Gebuhr
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.